Even considering the existence of a partial PD-1-independent immune-stimulatory activity operated by PD-L2,56,57 its presence at the surface of tumour cells may potentially counteract current therapeutic strategies based on PD-L1 blocking antibodies. Here, CD274 is linked to neoplasm.